N-Acétyl L-Cystéine 60 Gélules
Food supplement declared in France, declaration No 2019-5-1047
N-Acétyl L-Cystéine 60 Gélules (PROZIS) is a food supplement declared in France. Status: withdrawn from the market on 24 September 2024. Main ingredients: Acétylcystéine. 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Withdrawn from the market on 24 September 2024
- Form
- Capsule
- Daily dose
- 1 gélule
- Directions for use
- Prendre 1 gélule par jour, de préférence pendant un repas.
- Intended populations
- Children aged 4 to 10, Men
Declaration 164176, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Acétylcystéine | not declared |
Additives
E460, E551, E470b, E171
Other ingredients
gélatine, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la porte´e des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Information
Withdrawn from the market on 24 September 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Acétylcystéine
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- N-Acétyl L-Cystéine 60 Gélules PROZIS, declared in 2022, withdrawn from the market : different composition: 0 ingredient(s) added, 1 missing
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “N-Acétyl L-Cystéine 60 Gélules (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/164176-n-acetyl-l-cysteine-60-gelules, updated 15 November 2026.